WallStreetZenWallStreetZen

NASDAQ: NRC
Nrc Health Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Nrc Health earnings were $5.9M for the trailing 12 months ending Jun 30, 2026, with -68.8% growth year over year. The latest NRC earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$3.3M, down 201.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, NRC reported annual earnings of $11.6M, with -53.2% growth. The next NRC earnings date is Oct 26, 2026.

NRC past earnings growth

How has NRC's earnings growth performed historically?

Company
-68.83%
Industry
58.95%
Market
92.4%
NRC's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
NRC's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
NRC's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

NRC earnings history

Current Revenue
$140.0M
Current Earnings
$5.9M
Current Profit Margin
4.2%
NRC's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

NRC Return on Equity

Current Company
48.5%
Current Industry
7.3%
Current Market
30.9%
NRC's Return on Equity (48.5%)... subscribe to Premium to read more.
High Return on Equity Performance

NRC Return on Assets

Current Company
4.3%
Current Industry
3.9%
NRC is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when NRC announces earnings.

NRC Return on Capital Employed

Current Company
14.62%
Current Industry
9.2%
NRC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NRC vs Health Information Service Stocks

TickerEBITDAEarningsY/Y EarningsEPS
NRC$23.42M$5.86M-29.92%$0.24
CTEV$478.60M-$283.11MN/A-$17.01
EVH-$321.15M-$511.06MN/A-$4.49
CARL-$33.89M-$36.35MN/A-$1.08
SLP$18.17M$8.11M-7.48%$0.40
View Top Health Information Service Stocks

NRC earnings dates

Next earnings date
Oct 26, 2026

Nrc Health Earnings Reports & History FAQ

What were Nrc Health's earnings last quarter?

On NRC's earnings call on Jul 27, 2026, Nrc Health (NASDAQ: NRC) reported Q2 2026 earnings per share (EPS) of -$0.15, up 1,400% year over year. Total NRC earnings for the quarter were -$3.28 million. In the same quarter last year, Nrc Health's earnings per share (EPS) was -$0.01.

If you're new to stock investing, here's how to buy Nrc Health stock.

When does Nrc Health report earnings?

The next NRC earnings date is Oct 26, 2026. Add NRC to your watchlist to be reminded of Nrc Health's next earnings date.

Is Nrc Health profitable or losing money?

As of the last Nrc Health earnings report, Nrc Health is currently profitable. Nrc Health's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $5.86 million, a 67.32% decrease year over year.

What was NRC's earnings growth in the past year?

As of Nrc Health's earnings date in Jul 27, 2026, Nrc Health's earnings has grown -68.83% year over year. This is 127.78 percentage points lower than the US Health Information Services industry earnings growth rate of 58.95%. NRC earnings in the past year totalled $5.86 million.

What are Nrc Health's earnings expectations?

The current EPS estimate for Nrc Health's earnings report in Oct 26, 2026 is $0.21.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.